Origin Agritech Stock Price, News & Analysis

Origin Agritech (NASDAQ: SEED) announced its Hi3 corn haploid induction gene-editing technology was selected as one of the Top 10 Major Progresses in Chinese Agricultural Science for 2025 by the Chinese Academy of Agricultural Sciences. The Hi3 system, published in Nature in June 2024, enables efficient, fixed-point editing across diverse maize inbred lines and can shorten trait improvement by 3–4 years versus conventional backcrossing.

Origin reports it has developed more than 10 improved induction lines targeting leaf angle, drought and lodging resistance, extended growth periods, and plans to advance commercial gene-edited corn varieties in the coming years.

Origin Agritech (NASDAQ: SEED) entered a patent license agreement with Shandong Shunfeng Biotechnology to access the Cas-SF01 gene editing platform, securing long-term IP rights for trait gene editing.

Together with China Agricultural University, Origin developed edited corn induction lines ZmRAVL1-KO1 and ZmDWF4-KO1 that optimize leaf angle to create a "smart plant architecture" for higher planting density and improved light interception. The company has started biosafety assessments and says final biosafety certification may require 1-2 years. The license also aims to support biosafety approval for transformants using Origin's Hi-3 one-step editing method, advancing its commercial hybrid breeding roadmap.

Origin Agritech (NASDAQ: SEED) announced on October 24, 2025 a set of regulatory and corporate moves to expand seed production and GMO capabilities in China. The company obtained a Beijing crop seed production and operation license authorizing production, processing, packaging, wholesale and retail of corn seeds, adding to a second existing license held by its subsidiary in Xinjiang.

Beijing Tongzhou authorities also approved the inclusion of GMO crop seed production in the company's business scope (individual GMO crop registrations remain required). Origin raised the registered capital of Beijing Origin Seed from RMB 30 million to RMB 100 million and consolidated key production and sales entities under Beijing Origin as its primary operational hub.

Origin Agritech (NASDAQ: SEED) completed a Northeast Variety Showcase and Technology Seminar in Changchun on Sept 18–19, 2025, marking its re-entry into the Northeast China market and drawing more than 200 dealers and partners. The event introduced newly nationally approved corn varieties including Jinqiao 8, Jingke 4580, and Jingke 317, which the company says show high yield potential, disease resistance, and regional adaptability. Origin announced a collaboration agreement with Fengtian Seed Industry to commercialize premium varieties and highlighted progress on its transgenic BBL2-2 event and gene‑editing work with China Agricultural University. The company also launched dealer programs to support market penetration and sales growth.

Origin Agritech (NASDAQ: SEED), a leading Chinese agricultural technology company, has secured significant investments totaling $3.88 million. CEO Weibin Yan personally invested $2.4 million to acquire 2 million ordinary shares at $1.20 per share.

The company also modified an existing agreement with institutional investors, consolidating remaining tranches into a single closing worth $1.48 million at the same share price. These investments will fund Origin's expansion in China's agricultural biotechnology sector, supporting R&D, market penetration, and distribution network enhancement.

Origin Agritech (NASDAQ: SEED) announced a significant board restructuring, reducing its Board of Directors from seven to five members. The company appointed two new independent directors: Dr. Changqing Mao as Chairman of the Nomination Committee and Mr. Siu Laam Hau as Chairman of the Audit Committee.

Four existing directors - Ms. Fei Wang, Dr. Michael Trimble, Dr. Min Lin, and Mr. Chi Kin Cheng - resigned effective September 12, 2025, with Mr. Cheng maintaining his role as CFO. Dr. Mao brings extensive agricultural industry expertise, having held leadership positions at CITIC AgriScience and Yuan Longping Agricultural High-Tech. Mr. Hau contributes significant financial oversight experience as a Fellow Member of HKICPA and Executive Director of Asian Capital Limited.

Origin Agritech (NASDAQ: SEED) has launched full-scale seed processing operations at its Xinjiang production facility on August 21, 2025. The strategically located facility leverages Xinjiang's favorable solar thermal resources and climate conditions for optimal corn seed production.

The facility features a fully automated processing line that integrates cleaning, drying, threshing, precision sorting, coating, and packaging operations. Key technological features include advanced seed coating for crop protection and real-time monitoring systems for moisture content optimization.

This operational milestone strengthens Origin's integrated seed production and distribution strategy, enhancing its capability to supply high-quality corn seeds across China's agricultural markets while supporting national food security objectives.

Origin Agritech (NASDAQ: SEED) successfully hosted its Achievements Exhibition and Seed Industry Innovation Summit in Zhengzhou, attracting over 700 distributor partners and 30 industry experts. The event showcased four new corn varieties: Jingke 317, Jinqiao 8, Xundan 203, and Aoyu 728, all of which have received various regulatory approvals across multiple Chinese provinces.

The summit featured the launch of the "Golden Harvest Club" strategic alliance and presented the company's eight-year strategic development plan. Notable agricultural experts, including Professor Dai Jingrui and Chief Corn Scientist Wang Haiyang, attended the event and provided endorsements for Origin's products, particularly the Jingke 317 variety.

Origin Agritech (NASDAQ: SEED) reported financial results for the six months ended March 31, 2025, showing a decline in performance. Revenue decreased to $10.1 million from $13.0 million year-over-year, with a net loss of $3.6 million compared to a $0.2 million profit in the previous year.

Despite financial challenges, the company made significant strategic advances, including establishing the Origin Marker Biological Breeding Service Consortium and forming partnerships with China Agricultural University and 12 prominent agricultural companies. The company continues to progress with its GMO corn hybrid trials, with one hybrid expected for approval in 2025 and two in 2026.

The company's cash position decreased to $0.33 million from $1.2 million, while maintaining total borrowings at $0.69 million.